AsfuA.18272.a
FK506-binding protein 1A (FKBP) (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase) (PPIase) (Rapamycin-binding protein)
CENTER ID:
AsfuA.18272.a
ORGANISM:
Aspergillus fumigatus
ASSOCIATED DISEASE:
Aspergillosis
CURRENT STATUS:
in PDB
COMMUNITY REQUEST:
True
NIH RISK GROUP:
2
SELECT AGENT:
False
NIH PRIORITY
pathogens category:
unclassified
Ordering Clones & Proteins
If there are materials available for this target, they will be listed below.
Materials can be ordered from SSGCID using the button in the "order material" column.
Clicking the button will add the material to a virtual cart.
You may order multiple materials at a time at no cost to you, as this contract is funded
by NIAID. When you are ready to place your order, click the "Place Order" link which will
appear in the top right corner of the page after you place your first item in your cart.
Proteins
CENTER REFERENCE ID
DOMAIN/REGION DESCRIPTION
INFO
AA START
AA STOP
ORDER MATERIAL
AsfuA.18272.a.TM11.PD38408
full length
info
2
112
PD38408
AsfuA.18272.a.JA12.PD38420
full length
info
1
112
PD38420
Structures
7U0U
DEPOSITED: 2/18/2022
DETERMINATION: XRay
CLONE: AsfuA.18272.a.JA12.GE41919
PROTEIN: AsfuA.18272.a.JA12.PD38437
7U0S
DEPOSITED: 2/18/2022
DETERMINATION: XRay
CLONE: AsfuA.18272.a.TM11.GE43470
PROTEIN: AsfuA.18272.a.TM11.PD38408
Publications by SSGCID
Structure-Guided Synthesis of FK506 and FK520 Analogs with Increased Selectivity Exhibit In Vivo Therapeutic Efficacy against Cryptococcus
Fox D, Pierce PG, Hoy M, Juvvadi PR, Bobay B, Cole D, Ciofani M, Heitman J, Steinbach W, DeBouver ND, Park E, Lee H, Lim WY, Hong J
MBio - 2022
Sequences
These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols.
To find the specific sequence of any material you may have ordered, click on the "info" button next to the name of that material.
AA Sequence
MGVTKELKSP GNGVDFPKKG DFVTIHYTGR LTDGSKFDSS VDRNEPFQTQ IGTGRVIKGW DEGVPQMSLG EKAVLTITPD YGYGARGFPP VIPGNSTLIF EVELLGINNK RA
NT Sequence
atgggtgtca ccaaggaact caagtccccc ggcaacggtg tcgacttccc caagaagggc gactttgtca ccatccacta cactggtaga ctgaccgatg gctcaaagtt cgacagctcc gtcgaccgga acgaaccctt ccagacccag atcggtactg gccgtgtcat caagggttgg gatgagggtg tccctcagat gagccttggc gagaaggctg tcctcaccat tacccctgac tacggctacg gcgctcgtgg gttccctccc gtcatccctg gcaactctac cctcatcttc gaggttgagc ttcttggcat caacaacaag agggcttag
Details for AsfuA.18272.a.TM11.PD38408
PURIFICATION DATe:
11/18/2019
CONCENTRATION:
18.2mg/ml
OBSERVED MW:
14kDa
EXPRESSION LEVEL:
High Expression
PROTEIN PURIFICATION BUFFER:
25mM tris pH 8.0, 200mM NaCl, 1mM TCEP
EXPRESSION HOST:
BL21(DE3) + pBirA (adds CmR)
VIAL COUNT (approx.):
49
VIAL VOLUME:
200µl
PERCENT IDENTITY:
data unavailable
PERCENT COVERAGE:
data unavailable
Details for AsfuA.18272.a.JA12.PD38420
PURIFICATION DATe:
2/16/2020
CONCENTRATION:
7.17mg/ml
OBSERVED MW:
12kDa
EXPRESSION LEVEL:
Low Expression
PROTEIN PURIFICATION BUFFER:
25mM tris pH 8.0, 200mM NaCl, 1mM TCEP
EXPRESSION HOST:
BL21 DE3
VIAL COUNT (approx.):
6
VIAL VOLUME:
50µl
PERCENT IDENTITY:
data unavailable
PERCENT COVERAGE:
data unavailable